2023
Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes
Jiang D, Herrin J, Van Houten H, McCoy R. Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes. JAMA Network Open 2023, 6: e2250602. PMID: 36662531, PMCID: PMC9860518, DOI: 10.1001/jamanetworkopen.2022.50602.Peer-Reviewed Original ResearchConceptsHigh-deductible health plansSevere hypoglycemiaED visitsHealth plansCohort studyHDHP enrollmentPotential treatment selection biasAcute diabetes complicationsGlucose-lowering medicationsRetrospective cohort studyOptimal diabetes careAdministrative claims dataTreatment selection biasMixed effects logistic regression modelsLogistic regression modelsGlycemic complicationsGlycemic controlPatient ageDiabetes complicationsDiabetes careHospital visitsStudy populationInverse propensity scoreMAIN OUTCOMEClaims data
2015
Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010.
McCoy RG, Zhang Y, Herrin J, Denton BT, Mason JE, Montori VM, Smith SA, Shah ND. Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010. The American Journal Of Managed Care 2015, 21: e288-96. PMID: 26167776.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAdolescentAdultAge FactorsAgedBlood GlucoseComorbidityDiabetes Mellitus, Type 2Drug Therapy, CombinationFemaleGlycated HemoglobinHumansHypoglycemic AgentsIncretinsInsurance Claim ReviewMaleMetforminMiddle AgedResidence CharacteristicsRetrospective StudiesSex FactorsSocioeconomic FactorsSulfonylurea CompoundsUnited StatesYoung AdultConceptsTreatment intensificationCox proportional hazards regression analysisNational administrative data setProportional hazards regression analysisRetrospective secondary data analysisDiabetes treatment intensificationOptimal diabetes careHazards regression analysisDiabetes-related complicationsAdults 18 yearsTreatment-naïve adultsNon-Hispanic whitesComorbidity burdenMetformin monotherapySulfonylurea useMetformin prescriptionThiazolidinedione useGlycemic controlKaplan-MeierMean ageDiabetes careSignificant confoundersSecondary data analysisAdministrative data setsDiabetes therapy